These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4850175)

  • 1. A comparison of baclofen and diazepam in the treatment of spasticity.
    Cartlidge NE; Hudgson P; Weightman D
    J Neurol Sci; 1974 Sep; 23(1):17-24. PubMed ID: 4850175
    [No Abstract]   [Full Text] [Related]  

  • 2. Diazepam in the relief of muscle spasm resulting from spinal-cord lesions.
    Neill RW
    Ann Phys Med; 1964; Suppl():33-8. PubMed ID: 5825181
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Glass A; Hannah A
    Paraplegia; 1974 Nov; 12(3):170-4. PubMed ID: 4616209
    [No Abstract]   [Full Text] [Related]  

  • 4. Baclofen in the treatment of spasticity.
    Hudgson P; Weightman D
    Br Med J; 1971 Oct; 4(5778):15-7. PubMed ID: 4938243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis.
    From A; Heltberg A
    Acta Neurol Scand; 1975 Feb; 51(2):158-66. PubMed ID: 1090103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diazepam on muscle contraction in spasticity.
    Verrier M; Ashby P; MacLEOD S
    Am J Phys Med; 1976 Aug; 55(4):184-91. PubMed ID: 961832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaba derivative in spasticity. (Beta-(4-chlorophenyl)-gamma-aminobutyric acid, Ciba 34.647-Ba).
    Pedersen E; Arlien-Soborg P; Grynderup V; Henriksen O
    Acta Neurol Scand; 1970; 46(3):257-66. PubMed ID: 4918508
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of spasticity in multiple sclerosis: comparison of dantrolene sodium and diazepam.
    Schmidt RT; Lee RH; Spehlmann R
    Trans Am Neurol Assoc; 1975; 100():235-7. PubMed ID: 1226625
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.
    Hedley DW; Maroun JA; Espir ML
    Postgrad Med J; 1975 Sep; 51(599):615-8. PubMed ID: 1105499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a GABA--derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study.
    Basmajian JV; Yucel V
    Am J Phys Med; 1974 Oct; 53(5):223-8. PubMed ID: 4153338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-quatitative evaluation of the action of Ciba 34.647-Ba on spasticity].
    Roitman I; Anghinah A
    Arq Neuropsiquiatr; 1977 Dec; 35(4):354-61. PubMed ID: 588090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new agent for the control of spasticity.
    Jones RF; Burke D; Marosszeky JE; Gillies JD
    J Neurol Neurosurg Psychiatry; 1970 Aug; 33(4):464-8. PubMed ID: 4918459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis.
    Knutsson E; Lindblom U; Mårtensson A
    J Neurol Sci; 1974 Nov; 23(3):473-84. PubMed ID: 4154365
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacloffen (Lioresal) in the long-term management of spasticity.
    Jones RF; Lance JW
    Med J Aust; 1976 May; 1(18):654-7. PubMed ID: 820953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of diazepam on presynaptic inhibition in patients with complete and incomplete spinal cord lesions.
    Verrier M; MacLeod S; Ashby P
    Can J Neurol Sci; 1975 Aug; 2(3):179-84. PubMed ID: 1175099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT; Lee RH; Spehlmann R
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on spasticity. I. Diazepam in the treatment of spasticity. Considerations on its management in clinical practice and neurological rehabilitation].
    Giménez Roldán S; Martínez Fuertes L; Avila J
    Rev Clin Esp; 1969 Nov; 115(3):197-208. PubMed ID: 5405432
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study.
    Duncan GW; Shahani BT; Young RR
    Neurology; 1976 May; 26(5):441-6. PubMed ID: 772461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L; Henney HR; Runyan JD
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.